Novoray Corporation
SSE:688300.SS
57.48 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 960.36 | 711.682 | 661.954 | 624.71 | 404.203 | 315.301 | 278.106 | 210.96 | 153.633 | 122.362 | 125.327 | 120.499 | 108.535 |
| Cost of Revenue
| 572.603 | 432.287 | 402.485 | 359.446 | 231.044 | 169.288 | 158.888 | 123.911 | 88.314 | 71.601 | 73.662 | 73.656 | 65.588 |
| Gross Profit
| 387.758 | 279.395 | 259.47 | 265.264 | 173.159 | 146.013 | 119.218 | 87.05 | 65.319 | 50.76 | 51.665 | 46.843 | 42.947 |
| Gross Profit Ratio
| 0.404 | 0.393 | 0.392 | 0.425 | 0.428 | 0.463 | 0.429 | 0.413 | 0.425 | 0.415 | 0.412 | 0.389 | 0.396 |
| Reseach & Development Expenses
| 60.401 | 47.404 | 38.499 | 35.056 | 19.784 | 12.833 | 10.556 | 8.273 | 7.125 | 0 | 0 | 0 | 6.708 |
| General & Administrative Expenses
| 13.833 | 12.12 | 8.446 | 7.283 | 5.926 | 8.015 | 3.541 | 15.321 | 11.27 | 18.08 | 20.046 | 20.896 | 18.856 |
| Selling & Marketing Expenses
| 8.872 | 8.92 | 9.951 | 8.447 | 7.203 | 22.009 | 19.747 | 16.419 | 14.319 | 11.752 | 9.957 | 8.883 | 8.164 |
| SG&A
| 22.705 | 21.04 | 18.397 | 15.73 | 13.13 | 30.024 | 23.288 | 31.739 | 25.589 | 29.832 | 30.003 | 29.779 | 27.02 |
| Other Expenses
| 19.346 | 15.568 | 28.8 | 29.57 | 24.746 | 17.6 | -0.012 | 1.995 | 9.263 | 3.482 | 5.159 | 3.193 | 3.528 |
| Operating Expenses
| 102.452 | 84.012 | 85.696 | 80.356 | 57.659 | 60.457 | 49.084 | 40.465 | 34.357 | 30.923 | 31.078 | 30.42 | 27.788 |
| Operating Income
| 285.305 | 195.383 | 190.199 | 197.227 | 123.899 | 85.126 | 67.895 | 47.338 | 28.975 | 17.578 | 16.669 | 13.426 | 12.37 |
| Operating Income Ratio
| 0.297 | 0.275 | 0.287 | 0.316 | 0.307 | 0.27 | 0.244 | 0.224 | 0.189 | 0.144 | 0.133 | 0.111 | 0.114 |
| Total Other Income Expenses Net
| 0.883 | 1.979 | 2.953 | 0.173 | 4.471 | 1.709 | -0.012 | 1.995 | 9.263 | 3.482 | 5.159 | 3.193 | 0.796 |
| Income Before Tax
| 286.188 | 197.361 | 193.152 | 197.4 | 128.371 | 86.834 | 67.883 | 49.333 | 38.238 | 21.06 | 21.828 | 16.62 | 15.898 |
| Income Before Tax Ratio
| 0.298 | 0.277 | 0.292 | 0.316 | 0.318 | 0.275 | 0.244 | 0.234 | 0.249 | 0.172 | 0.174 | 0.138 | 0.146 |
| Income Tax Expense
| 34.814 | 23.367 | 4.912 | 24.532 | 17.454 | 12.139 | 9.516 | 7.085 | 5.529 | 2.841 | 2.922 | 2.38 | 1.879 |
| Net Income
| 251.374 | 173.994 | 188.241 | 172.868 | 110.916 | 74.695 | 58.366 | 42.249 | 32.709 | 18.219 | 18.906 | 14.24 | 14.019 |
| Net Income Ratio
| 0.262 | 0.244 | 0.284 | 0.277 | 0.274 | 0.237 | 0.21 | 0.2 | 0.213 | 0.149 | 0.151 | 0.118 | 0.129 |
| EPS
| 1.35 | 0.94 | 1.01 | 0.93 | 0.6 | 0.4 | 0.43 | 0.32 | 0.26 | 0.15 | 0.16 | 0.18 | 0.12 |
| EPS Diluted
| 1.35 | 0.94 | 1.01 | 0.93 | 0.6 | 0.4 | 0.43 | 0.32 | 0.26 | 0.15 | 0.16 | 0.18 | 0.12 |
| EBITDA
| 342.874 | 249.509 | 231.78 | 220.603 | 144.985 | 100.773 | 81.162 | 57.587 | 47.47 | 26.994 | 26.176 | 21.589 | 20.519 |
| EBITDA Ratio
| 0.357 | 0.351 | 0.35 | 0.353 | 0.359 | 0.32 | 0.292 | 0.273 | 0.309 | 0.221 | 0.209 | 0.179 | 0.189 |